Literature DB >> 11859391

Transient hematopoietic stem cell rescue using umbilical cord blood for a lethally irradiated nuclear accident victim.

H Nagayama1, K Misawa, H Tanaka, J Ooi, T Iseki, A Tojo, K Tani, Y Yamada, H Kodo, T A Takahashi, N Yamashita, S Shimazaki, S Asano.   

Abstract

We performed stem cell rescue and allogeneic skin transplantation on a lethally neutron-irradiated nuclear accident victim. HLA-DRB1 mismatched unrelated umbilical cord blood cells (2.08 x 10(7)/kg recipient body weight) were transplanted to an 8-10 Gy equivalent neutron-irradiated patient because of a lack of a suitable bone marrow or peripheral blood donor. Pre-transplant conditioning consisted of anti-thymocyte gamma-globulin alone, and GVHD prophylaxis was a combination of cyclosporine (CYA) and methylprednisolone (mPSL). Granulocyte colony-stimulating factor (G-CSF), erythropoietin (EPO), and thrombopoietin (TPO) were concurrently administered after transplantation. The absolute neutrophil count reached 0.5 x 10(9)/l on day 15, the reticulocyte count rose above 1% on day 23, and the platelet count was over 50 x 10(9)/l on day 27, respectively. Cytogenetic studies of blood and marrow showed donor/recipient mixed chimerism. Rapid autologous hematopoietic recovery was recognized after withdrawal of CYA and mPSL. Repeated pathological examinations of the skin revealed no evidence of acute GVHD. Eighty-two days after the irradiation, skin transplantation was performed to treat radiation burns. Almost 90% of the transplanted skin engrafted. Immunological examination after autologous hematopoietic recovery revealed an almost normal T cell count. However, immune functions were severely impaired. The patient died from infectious complication 210 days after the accident.

Entities:  

Mesh:

Year:  2002        PMID: 11859391     DOI: 10.1038/sj.bmt.1703356

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  21 in total

1.  After the bomb drops: a new look at radiation-induced multiple organ dysfunction syndrome (MODS).

Authors:  Jacqueline P Williams; William H McBride
Journal:  Int J Radiat Biol       Date:  2011-03-21       Impact factor: 2.694

2.  A nonhuman primate model of the hematopoietic acute radiation syndrome plus medical management.

Authors:  Ann M Farese; Melanie V Cohen; Barry P Katz; Cassandra P Smith; William Jackson; Daniel M Cohen; Thomas J MacVittie
Journal:  Health Phys       Date:  2012-10       Impact factor: 1.316

Review 3.  Current status of hematopoietic stem cell transplantation for acute radiation syndromes.

Authors:  Shigetaka Asano
Journal:  Int J Hematol       Date:  2012-03-03       Impact factor: 2.490

Review 4.  Pharmacological management of ionizing radiation injuries: current and prospective agents and targeted organ systems.

Authors:  Vijay K Singh; Thomas M Seed
Journal:  Expert Opin Pharmacother       Date:  2020-01-11       Impact factor: 3.889

5.  In vitro and in vivo assessment of direct effects of simulated solar and galactic cosmic radiation on human hematopoietic stem/progenitor cells.

Authors:  C Rodman; G Almeida-Porada; S K George; J Moon; S Soker; T Pardee; M Beaty; P Guida; S P Sajuthi; C D Langefeld; S J Walker; P F Wilson; C D Porada
Journal:  Leukemia       Date:  2016-11-24       Impact factor: 11.528

6.  Cellular Therapies for Treatment of Radiation Injury: Report from a NIH/NIAID and IRSN Workshop.

Authors:  Andrea L DiCarlo; Radia Tamarat; Carmen I Rios; Marc Benderitter; Christine W Czarniecki; Theresa C Allio; Francesca Macchiarini; Bert W Maidment; Jean-Rene Jourdain
Journal:  Radiat Res       Date:  2017-06-12       Impact factor: 2.841

7.  Cellular Therapies for Treatment of Radiation Injury after a Mass Casualty Incident.

Authors:  Carmen Rios; Jean-René Jourdain; Andrea L DiCarlo
Journal:  Radiat Res       Date:  2017-06-13       Impact factor: 2.841

8.  Severe immune dysfunction after lethal neutron irradiation in a JCO nuclear facility accident victim.

Authors:  Hitomi Nagayama; Jun Ooi; Akira Tomonari; Tohru Iseki; Arinobu Tojo; Kenzaburo Tani; Tsuneo A Takahashi; Naohide Yamashita; Asano Shigetaka
Journal:  Int J Hematol       Date:  2002-08       Impact factor: 2.490

Review 9.  Ghrelin as a novel therapy for radiation combined injury.

Authors:  Asha Jacob; Kavin G Shah; Rongqian Wu; Ping Wang
Journal:  Mol Med       Date:  2010-01-19       Impact factor: 6.354

Review 10.  Repurposing Pharmaceuticals Previously Approved by Regulatory Agencies to Medically Counter Injuries Arising Either Early or Late Following Radiation Exposure.

Authors:  Vijay K Singh; Thomas M Seed
Journal:  Front Pharmacol       Date:  2021-05-10       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.